Design and optimization of immediate release tablet of salbutamol sulphate by direct compression technique
Keywords:Salbutamol Sulphate, immediate release drug delivery system, immediate release tablet, super disintegrant
This study is about a tablet, which disintegrates or dissolves quickly when placed in the oral cavity. Studies on formulation development of Salbutamol Sulphate Immediate Release Tablet, suitable for manufacturing by direct compression have been carried out. Trial formulations using various excipients were developed and evaluated for various qualities like hardness, friability, disintegration time, content uniformity and dissolution. Study concluded that Immediate Release Tablet of Salbutamol Sulphate can be prepared successfully with added patient benefit and increased consumer satisfaction.
Slowson M and Slowson S. What to do when patients cannot swallow their medications. Pharma Times, 51, 90‐96 (1985)
Indurwade NH, Rajyaguru TH and Nakhat PD. Novel approach: Fast dissolving tablets. Indian Drugs, 39(8), 405‐41 (2002)
Seager HJ. Drug delivery products and zydis fast dissolving dosage forms. Pharm Pharmcol, 50:375‐382 (1998)
Gohel M, Patel M, Amin A, Agrawal R, Dave R and Bariya N. Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique. AAPS Pharm Sci Tech, 5, 36 (2004)
Reddy LH, Ghosh B and Rajneesh. Fast dissolving drug delivery system: A review of literature. Indian J Pharm Sci, 64 (4), 331‐336 (2002)
Habib W, Khankari R and Hontz J. Fast‐dissolving drug delivery systems: Critical review in therapeutics. Drug Carrier Systems, 17(1), 61‐72 (2002)
Biradar SS, Bhagavati ST and Kuppasad IJ. Fast dissolving drug delivery systems: A brief overview. The Int J Pharmacol, 4(2). (2006)
Bhaskaran S, Narmada GV. Rapid Dissolving tablet A Novel dosage form. Indian Pharmacist, 1, 9‐12 (2002)
Devrajan PV and Gore SP, Melt‐ in‐ mouth tablets: innovative oral drug delivery system. Express Pharma Pulse, 7(1), 16 (2000)
Bolhius GK, Zuurman K and Te‐Wierik GH. Improvement of dissolution of poorly soluble drugs by solid deposition on a superdisintegrant. Part 2. Choice of super disintegrants and effect of granulation. Eur J Pharm Sci, 5(2), 63–69 (1997)
Kuchekar BS, Badhan CA and Mahajan HS. Mouth dissolving tablets: A novel drug delivery system. Pharma Times, 35, 7‐10 (2003)
Yarwood RJ, Kearny P and Thomson AR. Process for preparing solid pharmaceutical dosage forms. US Patent No. 5738875 (1998)
Mizumoto T, Masuda Y and Fukui M. Intrabuccally dissolving compressed moldings and production process thereof. US Patent No. 5576014 (1996)
Kaushik D, Dureja H and Saini TR. Mouth dissolving tablets: A Review. Indian Drugs, 41(4),187‐192 (2004)
Gole DJ, Levinson RS and Carbone J. Preparation of pharmaceutical and other matrix systems by solid state dissolution. US Patent, No. 5215756 (1993)
How to Cite
Copyright (c) 2020 Suman Saha
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
In submitting an article to Journal of Applied Pharmaceutical Research (JOAPR) I certify that:
- I am authorized by my co-authors to enter into these arrangements.
- I warrant, on behalf of myself and my co-authors, that:
- the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights;
- I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to JOAPR are not in breach of any other obligation;
- the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
- I/we have taken due care to ensure the integrity of the article. To my/our - and currently accepted scientific - knowledge all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage to the user.
- I, and all co-authors, agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution-NonCommercial 4.0 International License
- I, and all co-authors, agree that, if the article is editorially accepted for publication in Journal of Applied Pharmaceutical Research (JOAPR) data included in the article shall be made available under the Creative Commons 1.0 Public Domain Dedication waiver, unless otherwise stated. For the avoidance of doubt it is stated that sections 1, 2, and 3 of this license agreement shall apply and prevail.